You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
ENHANCED DENTAL AMALGAM TRAP
SBC: ADA TECHNOLOGIES, INC. Topic: N/ADESCRIPTION: Surveys conducted by municipal wastewater treatment plants across the country have concluded that anywhere from 10 percent to over 70 percent of the mercury reaching the plants comes from Dental offices. These findings, combined with increasingly stringent regulations on mercury discharges, have placed pressure on the Dental profession to reduce their dis ...
SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health -
SELF-DISINFECTING WATERLINE TUBING FOR DENTAL OFFICES
SBC: ADA TECHNOLOGIES, INC. Topic: N/ADESCRIPTION: The goal of this new SBIR application is to develop an economical Dental waterline that resists biofilm formation and growth. The proposed waterline will utilize a photocatalytic oxidation system to inhibit microbial growth. Such a system would obviate the need for extraneous chemicals and would allow continuous cleansing of the waterlines. The photoreact ...
SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health -
LUNG DRUG DELIVERY WITH CARBON DIOXIDE AEROSOL INHALERS
SBC: AEROPHASE, INC. Topic: N/ADESCRIPTION (Adapted from the Investigator's Abstract): The chlorofluorocarbon (CFC) propellants currently being used in metered dose inhalers for pulmonary drug delivery are being phased out due to their high ozone depletion potential. An international pharmaceutical industry consortium has proposed that the zero-ozone depletion potential hydrofluoroalkane (HFA) propel ...
SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health -
Implantable Noise-Based Sensory Enhancement Devices
SBC: AFFERENT CORPORATION Topic: N/AStochastic resonance (SR) is a counterintuitive phenomenon in which slight amounts of noise imparted to a system actually increase its sensitivity to weak stimuli. SR has been shown to produce a demonstrable effect in human sensory cells. In both healthy young and clinical subjects - elderly, diabetics, and stroke sufferers - a notable increase in tactile and proprioceptive sensitivity is seen whe ...
SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health -
ENHANCING THE TACTILE SENSE USING MECHANICAL NOISE
SBC: AFFERENT CORPORATION Topic: N/AStochastic resonance (SR), a counterintuitive phenomenon in which slight amounts of environmental noise actually increase the discernability of signals or stimuli, produces a demonstrable effect in human sensory cells. In both healthy young and clinical subjects- elderly, diabetics, and stroke sufferers-a significant increase in tactile and proprioceptive sensitivity is noted when electrical or me ...
SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health -
Restoring Diabetic Tactile Sense with Mechanical Noise
SBC: AFFERENT CORPORATION Topic: N/AStochastic resonance (SR) is a counterintuitive phenomenon in which slight amounts of noise imparted to a system actually increase its sensitivity to weak stimuli. SR has been shown to produce a demonstrable effect in human sensory cells. In both healthy young and clinical subjects-elderly, diabetics, and stroke sufferers-a notable increase in tactile and proprioceptive sensitivity is seen when el ...
SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health -
Dismounted C4ISR Data Presentation and Dissemination by the Army Research Laboratory (ARL)
SBC: Applied Technologies, Inc. Topic: N/AThis Phase I proposal responds to the need for a low-power, expendable, remote sensor array that can be emplaced and positioned to provide battlefield environmental data.Applied Technologies, Inc. proposes to design and conduct testing on a remote sensorarray capable of accommodating a multitude of sensors, including wind speed and direction, visibility, precipitation, atmospheric pressure and tem ...
SBIR Phase I 2001 Department of DefenseOffice of the Secretary of Defense -
PEPTIDE FOR GENTLE PURIFICATION OF BIOTINYLATED PROTEIN
SBC: Avidity, LLC Topic: N/ADESCRIPTION (provided by applicant): Affinity tag technology has become increasingly important for immobilizing proteins for high-throughput screening, for generating protein arrays, and for simplifying protein purification. There is a pressing need for economical and technically simple technologies to immobilize or purify proteins. None of the existing molecula ...
SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health -
LONG-ACTING GM-CSF PROTEINS FOR TREATING NEUTROPENIA
SBC: BOLDER BIOTECHNOLOGY INC Topic: N/ADESCRIPTION: (Investigator's abstract) Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) is a cytokine that stimulates proliferation and differentiation of hematopoietic progenitor cells. Recombinant human GM-CSF is used to stimulate neutrophil production in patients with neutropenia resulting from myelosuppressive chemotherapy. Recombinant human GMCSF ...
SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health -
LONG-ACTING GM-CSF PROTEINS FOR TREATING NEUTROPENIA
SBC: BOLDER BIOTECHNOLOGY INC Topic: N/ADESCRIPTION: (Investigator's abstract) Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) is a cytokine that stimulates proliferation and differentiation of hematopoietic progenitor cells. Recombinant human GM-CSF is used to stimulate neutrophil production in patients with neutropenia resulting from myelosuppressive chemotherapy. Recombinant human GMCSF ...
SBIR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health